Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Trans-4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f]triazin-7-yl]cyclohexanecarboxylic acid | 936890-98-1 | 100.0% | 406.44 g/mol | C21H22N6O3 | 1 ML
SDP

Catalog No. 5000243101
Encompass_Preferred

OSI-027 is a potent, ATP-competitive inhibitor of the mechanistic target of rapamycin (mTOR) that blocks both mTORC1 and mTORC2 and is used as a research tool in preclinical studies to probe mTOR signaling and anticancer activity. It is supplied as a 10 mM solution in DMSO (1 mL) and is also available as a solid form; molecular formula C21H22N6O3, molecular weight 406.44 g/mol, CAS 936890-98-1.

  • Potent dual mTORC1/mTORC2 inhibitor with low-nanomolar activity.
  • Supplied as a ready-to-use 10 mM solution in DMSO for convenient dosing.
  • Available as solid powder for custom formulation and storage.
  • High chemical purity suitable for research applications.
  • Stable when stored under recommended conditions for powder and solution.
  • Appropriate for preclinical oncology and signaling pathway studies.

Catalog No. 50-002-43101 Supplier Medchemexpress LLC Supplier No. HY1042310MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

OSI-027 is a potent, ATP-competitive inhibitor of the mechanistic target of rapamycin (mTOR) that blocks both mTORC1 and mTORC2 and is used as a research tool in preclinical studies to probe mTOR signaling and anticancer activity. It is supplied as a 10 mM solution in DMSO (1 mL) and is also available as a solid form; molecular formula C21H22N6O3, molecular weight 406.44 g/mol, CAS 936890-98-1.

  • Potent dual mTORC1/mTORC2 inhibitor with low-nanomolar activity.
  • Supplied as a ready-to-use 10 mM solution in DMSO for convenient dosing.
  • Available as solid powder for custom formulation and storage.
  • High chemical purity suitable for research applications.
  • Stable when stored under recommended conditions for powder and solution.
  • Appropriate for preclinical oncology and signaling pathway studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.